Sal B exerted a chondroprotective effect by upregulating KCNQ1OT1, which indicates Sal B can used for a therapeutic agent in obesity-related OA. The gene discussed is KCNQ1OT1; the disease is obesity due to melanocortin 4 receptor deficiency.